Scientific article
English

Dual NEP/ECE inhibition improves endothelial function in mesenteric resistance arteries of 32-week-old SHR

Published inHypertension Research, vol. 40, no. 8, p. 738-745
Publication date2017
Abstract

Endothelin 1 (ET-1), a potent vasoconstrictor, pro-mitogenic and pro-inflammatory peptide, may promote development of endothelial dysfunction and arterial remodeling. ET-1 can be formed through cleavage of big-ET-1 by endothelin-converting enzyme (ECE) or neutral endopeptidase (NEP). We investigated whether chronic treatment with the novel dual NEP/ECE inhibitor SOL1 improves functional and structural properties of resistance-sized arteries of 32-week-old male spontaneously hypertensive rats (SHR). SHR received a chronic 4-week treatment with SOL1, losartan or hydralazine. We then compared effects of inhibition of NO synthase (NOS) (100 μM l-NAME), blockade of ETA- and ETB-receptors (10 μM bosentan) and stimulation of the endothelium with 0.001-10 μM acetylcholine (ACh) in isolated third-order mesenteric resistance arteries. Losartan and hydralazine significantly lowered blood pressure. Losartan decreased the media-to-lumen ratio of resistance arteries. l-NAME (1) increased arterial contractile responses to K(+) (5.9-40 mM) in the losartan, SOL1 and vehicle group and (2) increased the sensitivity to phenylephrine (PHE; 0.16-20 μM) in the SOL1 group but not in the losartan, hydralazine and vehicle group. Relaxing responses to ACh in the absence or presence of l-NAME during contractions induced by either 10 μM PHE or 40 mM K(+) were not altered by any in vivo treatment. Acute treatment with bosentan did, however, significantly improve maximal relaxing responses involving endothelium-derived nitric oxide and -hyperpolarizing factors in the SOL1 group but not in the losartan, hydralazine or vehicle group. Thus, chronic inhibition of NEP/ECE improved basal endothelial function but did not alter blood pressure, resistance artery structure and stimulated endothelium-dependent relaxing responses in 32-week-old SHR.

Citation (ISO format)
LEMKENS, Pieter et al. Dual NEP/ECE inhibition improves endothelial function in mesenteric resistance arteries of 32-week-old SHR. In: Hypertension Research, 2017, vol. 40, n° 8, p. 738–745. doi: 10.1038/hr.2017.38
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0916-9636
446views
0downloads

Technical informations

Creation14/09/2017 12:08:00
First validation14/09/2017 12:08:00
Update time02/04/2025 07:06:38
Status update02/04/2025 07:06:38
Last indexation02/04/2025 07:13:21
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack